Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Christian Lubich is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Finished
-
Advanced personalized diagnostics to overcome severe side effects of protein therapeutics
Eger, A. (CoI), Lubich, C. (CoI), Allacher, P. (PI) & Paul, H. (CoI)
Gesellschaft für Forschungsförderung Niederösterreich
24/07/17 → 10/08/23
Project: Research
-
Caracterización de partículas subvisibles usando un analizador de partículas
Malisauskas, M. (Inventor), Lubich, C. (Inventor), Prenninger, T. (Inventor) & Reipert, B. (Inventor), 23 Nov 2022, Patent No. ES 2928973 T3Research output: Patent
-
Characterization of Subvisible Particles Using a Particle Analyzer
Malisauskas, M. (Inventor), Lubich, C. (Inventor), Prenninger, T. (Inventor) & Reipert, B. (Inventor), 27 Jul 2022, Patent No. EP 2802871 B1Research output: Patent
-
Characterization of Subvisible Particles Using a Particle Analyzer
Malisauskas, M. (Inventor), Lubich, C. (Inventor), Prenninger, T. (Inventor) & Reipert, B. (Inventor), 28 Sept 2022, (Submitted) Patent No. EP 4063854 A1Research output: Patent
-
Modulating the microenvironment during FVIII uptake influences the nature of FVIII-peptides presented by antigen-presenting cells
Lubich, C., Steinitz, K. N., Hoelbl, B., Prenninger, T., van Helden, P. M., Weiller, M. & Reipert, B. M., 21 Oct 2022, In: Frontiers in Immunology. 13, p. 975680 975680.Research output: Contribution to journal › Article › peer-review
Open Access -
Modulation of the liver immune microenvironment by the adeno-associated virus serotype 8 gene therapy vector
Carestia, A., Kim, S.-J., Horling, F., Rottensteiner, H., Lubich, C., Reipert, B. M., Crowe, B. A. & Jenne, C. N., 12 Mar 2021, In: Molecular Therapy Methods and Clinical Development. 20, p. 95—108 14 p.Research output: Contribution to journal › Article › peer-review
Open Access